We previously highlighted a study which found that institutional investors are using Freedom of Information Act (FOIA) requests – specifically, FDA FOIA requests – to generate abnormal returns. In this piece, we provide three examples of how investors have successfully utilised this FOIA technique to obtain early access to stock-moving information.

NEUDATA QUICK VIEW

We believe that information obtained through FOIA requests can serve as a valuable supplementary source of intelligence for equity investors. Supporting this